Global Exosomes Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Exosomes Market Overview

• 1.1 Product Overview and Scope of Exosomes
• 1.2 Classification of Exosomes by Type
  • 1.2.1 Global Exosomes Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Exosomes Revenue Market Share by Type in 2019
  • 1.2.3 Non-coding RNAs
  • 1.2.4 Lipids
  • 1.2.5 mRNA
  • 1.2.6 DNA fragments
  • 1.2.7 Proteins /peptides
• 1.3 Global Exosomes Market by Application
  • 1.3.1 Overview: Global Exosomes Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Cancer
  • 1.3.3 Infectious diseases
  • 1.3.4 Neurodegenerative diseases
  • 1.3.5 Cardiovascular diseases
• 1.4 Global Exosomes Market by Regions
  • 1.4.1 Global Exosomes Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Exosomes (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Exosomes Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Exosomes Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Exosomes Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Exosomes Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Exosomes Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Fujifilm
  • 2.1.1 Fujifilm Details
  • 2.1.2 Fujifilm Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Fujifilm SWOT Analysis
  • 2.1.4 Fujifilm Product and Services
  • 2.1.5 Fujifilm Exosomes Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Miltenyi Biotec
  • 2.2.1 Miltenyi Biotec Details
  • 2.2.2 Miltenyi Biotec Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Miltenyi Biotec SWOT Analysis
  • 2.2.4 Miltenyi Biotec Product and Services
  • 2.2.5 Miltenyi Biotec Exosomes Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Illumina
  • 2.3.1 Illumina Details
  • 2.3.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Illumina SWOT Analysis
  • 2.3.4 Illumina Product and Services
  • 2.3.5 Illumina Exosomes Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Thermo Fisher Scientific
  • 2.4.1 Thermo Fisher Scientific Details
  • 2.4.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Thermo Fisher Scientific SWOT Analysis
  • 2.4.4 Thermo Fisher Scientific Product and Services
  • 2.4.5 Thermo Fisher Scientific Exosomes Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Malvern Instruments
  • 2.5.1 Malvern Instruments Details
  • 2.5.2 Malvern Instruments Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Malvern Instruments SWOT Analysis
  • 2.5.4 Malvern Instruments Product and Services
  • 2.5.5 Malvern Instruments Exosomes Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Danaher
  • 2.6.1 Danaher Details
  • 2.6.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Danaher SWOT Analysis
  • 2.6.4 Danaher Product and Services
  • 2.6.5 Danaher Exosomes Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Lonza
  • 2.7.1 Lonza Details
  • 2.7.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Lonza SWOT Analysis
  • 2.7.4 Lonza Product and Services
  • 2.7.5 Lonza Exosomes Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Takara Bio
  • 2.8.1 Takara Bio Details
  • 2.8.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Takara Bio SWOT Analysis
  • 2.8.4 Takara Bio Product and Services
  • 2.8.5 Takara Bio Exosomes Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Qiagen
  • 2.9.1 Qiagen Details
  • 2.9.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Qiagen SWOT Analysis
  • 2.9.4 Qiagen Product and Services
  • 2.9.5 Qiagen Exosomes Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 MBL International
  • 2.10.1 MBL International Details
  • 2.10.2 MBL International Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 MBL International SWOT Analysis
  • 2.10.4 MBL International Product and Services
  • 2.10.5 MBL International Exosomes Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Exosomes Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Exosomes Players Market Share
  • 3.2.2 Top 10 Exosomes Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Exosomes Revenue and Market Share by Regions
• 4.2 North America Exosomes Revenue and Growth Rate (2015-2020)
• 4.3 Europe Exosomes Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Exosomes Revenue and Growth Rate (2015-2020)
• 4.5 South America Exosomes Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Exosomes Revenue and Growth Rate (2015-2020)

5 North America Exosomes Revenue by Countries

• 5.1 North America Exosomes Revenue by Countries (2015-2020)
• 5.2 USA Exosomes Revenue and Growth Rate (2015-2020)
• 5.3 Canada Exosomes Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Exosomes Revenue and Growth Rate (2015-2020)

6 Europe Exosomes Revenue by Countries

• 6.1 Europe Exosomes Revenue by Countries (2015-2020)
• 6.2 Germany Exosomes Revenue and Growth Rate (2015-2020)
• 6.3 UK Exosomes Revenue and Growth Rate (2015-2020)
• 6.4 France Exosomes Revenue and Growth Rate (2015-2020)
• 6.5 Russia Exosomes Revenue and Growth Rate (2015-2020)
• 6.6 Italy Exosomes Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Exosomes Revenue by Countries

• 7.1 Asia-Pacific Exosomes Revenue by Countries (2015-2020)
• 7.2 China Exosomes Revenue and Growth Rate (2015-2020)
• 7.3 Japan Exosomes Revenue and Growth Rate (2015-2020)
• 7.4 Korea Exosomes Revenue and Growth Rate (2015-2020)
• 7.5 India Exosomes Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Exosomes Revenue and Growth Rate (2015-2020)

8 South America Exosomes Revenue by Countries

• 8.1 South America Exosomes Revenue by Countries (2015-2020)
• 8.2 Brazil Exosomes Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Exosomes Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Exosomes by Countries

• 9.1 Middle East & Africa Exosomes Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Exosomes Revenue and Growth Rate (2015-2020)
• 9.3 UAE Exosomes Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Exosomes Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Exosomes Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Exosomes Revenue and Market Share by Type (2015-2020)
• 10.2 Global Exosomes Market Forecast by Type (2019-2024)
• 10.3 Non-coding RNAs Revenue Growth Rate (2015-2025)
• 10.4 Lipids Revenue Growth Rate (2015-2025)
• 10.5 mRNA Revenue Growth Rate (2015-2025)
• 10.6 DNA fragments Revenue Growth Rate (2015-2025)
• 10.7 Proteins /peptides Revenue Growth Rate (2015-2025)

11 Global Exosomes Market Segment by Application

• 11.1 Global Exosomes Revenue Market Share by Application (2015-2020)
• 11.2 Exosomes Market Forecast by Application (2019-2024)
• 11.3 Cancer Revenue Growth (2015-2020)
• 11.4 Infectious diseases Revenue Growth (2015-2020)
• 11.5 Neurodegenerative diseases Revenue Growth (2015-2020)
• 11.6 Cardiovascular diseases Revenue Growth (2015-2020)

12 Global Exosomes Market Size Forecast (2021-2025)

• 12.1 Global Exosomes Market Size Forecast (2021-2025)
• 12.2 Global Exosomes Market Forecast by Regions (2021-2025)
• 12.3 North America Exosomes Revenue Market Forecast (2021-2025)
• 12.4 Europe Exosomes Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Exosomes Revenue Market Forecast (2021-2025)
• 12.6 South America Exosomes Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Exosomes Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer